Stocks · Korea
033270
KOSPI
Korea United Pharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER6.87x
PBR0.63x
EPS2,614 KRW
BPS28,664 KRW
ROE8.63%
Dividend yield3.39%
DPS610 KRW
Payout ratio23.34%
Returns and 52-week range
1W+1.76%
1M-2.71%
3M+3.28%
6M-12.77%
1Y-10.60%
YTD-5.32%
52W high21,800원
52W low16,100원
From 52W high-17.57%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 2,625억 | 482억 | 453억 | 18.4% |
| 2023 | 2,789억 | 549억 | 483억 | 19.7% |
| 2024 | 2,887억 | 563억 | 325억 | 19.5% |
| 2025 | 2,888억 | 496억 | 383억 | 17.2% |
| Quarterly | ||||
| 2024 4Q | 732억 | 118억 | 144억 | 16.2% |
| 2025 1Q | 713억 | 138억 | 127억 | 19.3% |
| 2025 2Q | 704억 | 108억 | 12억 | 15.3% |
| 2025 3Q | 744억 | 125억 | 135억 | 16.8% |
| 2025 4Q | 726억 | 125억 | 109억 | 17.3% |
| 2026 1Q | 738억 | 113억 | 140억 | 15.2% |
Company
Address: 세종특별자치시 전동면 노장리 404-10
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 휴메딕스 | 2,914억 | 5.17 | 0.96 | +2.78% |
| 지놈앤컴퍼니 | 2,782억 | — | 2.21 | +58.81% |
| 에스바이오메딕스 | 2,927억 | — | 33.03 | +23.13% |
| 엔케이젠바이오텍코리아 | 2,655억 | — | 37.07 | +0.00% |
| 일성아이에스 | 2,953억 | 130.59 | 0.41 | +7.51% |
| 삼진제약 | 2,640억 | 10.10 | 0.86 | +5.31% |
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
- 2026-03-19[기재정정]사업보고서 (2025.12)
- 2026-03-16사업보고서 (2025.12)
- 2025-12-22주요사항보고서(자기주식처분결정) Major
- 2025-12-18주요사항보고서(자기주식처분결정) Major
- 2025-11-13분기보고서 (2025.09)
- 2025-09-25주요사항보고서(자기주식취득신탁계약해지결정) Major
- 2025-08-13반기보고서 (2025.06)
- 2025-07-28[기재정정]사업보고서 (2024.12)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.